https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Kuros Biosciences Launches MagnetOs Easypack Putty in the U.S. Kuros Biosciences Launches MagnetOs Easypack Putty in the U.S. MagnetOs Easypack Putty is ready to use with no requirement for thawing or mixing with blood or bone marrow aspirate. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Biogennix’s DirectCell Bone Grafting System Used in 500th Case Biogennix’s DirectCell Bone Grafting System Used in 500th Case DirectCell includes a bone graft with novel instrumentation engineered to harvest high concentrations of patient stem cells. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE APEX Biologix Launches Newly Reconfigured Bone Marrow System APEX Biologix Launches Newly Reconfigured Bone Marrow System XCELL BMC will provide system features specifically designed for surgery settings in hospitals, clinics and surgical centers. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE SeaSpine Launches OsteoTorrent DBM Product Families SeaSpine Launches OsteoTorrent DBM Product Families OsteoTorrent putties are packaged and sterilized in a dry state and designed to improve osteoinductive potential and shelf-life. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Royal Biologics Launches Advanced-Cell Bone Grafting Kit Royal Biologics Launches Advanced-Cell Bone Grafting Kit Advanced-Cell combines multiple autologous and advanced bone grafting technologies all in one convenience kit. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE OssDsign Completes Enrollment in Spinal Fusion Study OssDsign Completes Enrollment in Spinal Fusion Study The 2-year study will assess the use of OssDsign Catalyst synthetic bone graft in spinal fusion surgery. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE OssDsign Enrolls First Patient in U.S. PROPEL Registry OssDsign Enrolls First Patient in U.S. PROPEL Registry The multicenter, prospective spinal fusion registry will evaluate the use and outcome of Catalyst bone graft in real-world clinical practice. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Bone Therapeutics to Strategically Focus on ALLOB Cell Therapy Bone Therapeutics to Strategically Focus on ALLOB Cell Therapy ALLOB is the company's most advanced clinical asset. The product is currently engaged in a Phase IIb study to treat high-risk tibial fractures. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Synergy Biomedical Launches New BIOSPHERE Synthetic Bioactive Bone Graft Synergy Biomedical Launches New BIOSPHERE Synthetic Bioactive Bone Graft BIOSPHERE FLEX SP Extremities is a sheet putty comprising spherical bioactive glass granules plus a porous collagen/sodium hyaluronate carrier. Read more
https://www.orthoworld.com ORTHOWORLD JULIE A. VETALICE Synergy Biomedical Launches BIOSPHERE MIS II Bone Graft Delivery Synergy Biomedical Launches BIOSPHERE MIS II Bone Graft Delivery BIOSPHERE MIS II uses a pre-loaded bone graft cannula and a streamlined trigger-based system as a bone graft delivery solution. Read more